Still smiling at todays ann.
Does anyone think Dr Gittleson would not have asked for access to the full data before agreeing to be NED at a speculative ASX microcap?
She is used to winning at CSL, she wants to be part of a success story.
She would have seen the "special" P2 data that Prof. Voit raved about- in a more discerning way than we can ever imagine.....before making her decision.
Her appointment is definitely one of the catalysts that Wilson mentioned in their report.
The transformation has begun.
.
Ann: Antisense Therapeutics appoints new Non-Executive Director, page-28
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PER (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $94.66M | |||
| Open | High | Low | Value | Volume |
| 10.5¢ | 10.5¢ | 9.8¢ | $58.09K | 574.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 38503 | 10.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.5¢ | 194063 | 5 |
View Market Depth
| Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
| PER (ASX) Chart |